Cara Therapeutic
Price & Volume
Stats
See more52W Range | $2.70-$13.80 |
Market Cap | $23M |
Shares Short | 121,097 |
Financials
See moreRevenue (12 Mos) | $10.9M |
Revenue Growth (YoY) | -85.7% |
Gross Profit (12 Mos) | -$77.8M |
Diluted EPS | -$21 |
News
See moreYahoo Finance • last year
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica Program and Extends Cash Runway into 2026
Yahoo Finance • last year
Cara Therapeutics Reports Third Quarter 2023 Financial Results
Yahoo Finance • last year
Cara Therapeutics Announces up to $40.0 Million Non-Dilutive Financing Agreement with HealthCare Royalty
Yahoo Finance • last year
Cara Therapeutics to Announce Third Quarter 2023 Financial Results on November 13, 2023
About
CEO | Mr. Christopher A. Posner |
Address | 400 Atlantic Street, Stamford, CT, United States, 06901 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 55 |
